Area of research
Genetics · Epidemiology
Research interest
Research interests include Inflammatory Bowel Disease, Microscopic Colitis, Heart Rate Variability and Autonomic Control, and Eosinophilic Esophagitis.
Value of Engagement in Digital Health Technology Research: Evidence Across 6 Unique Cohort Studies
Current Trends in IBD—Development of Mucosal-Based Biomarkers and a Novel Minimally Invasive Recoverable Sampling System
Safety of Tofacitinib in a Real-World Cohort of Patients With Ulcerative Colitis
Development and Validation of Clinical Scoring Tool to Predict Outcomes of Treatment With Vedolizumab in Patients With Ulcerative Colitis
Longitudinal Autonomic Nervous System Measures Correlate With Stress and Ulcerative Colitis Disease Activity and Predict Flare
Comparative Safety and Effectiveness of Vedolizumab to Tumor Necrosis Factor Antagonist Therapy for Ulcerative Colitis
Real-World Effectiveness and Safety of Tofacitinib in Crohn’s Disease and IBD-U: A Multicenter Study From the TROPIC Consortium
Shorter Disease Duration Is Associated With Higher Rates of Response to Vedolizumab in Patients With Crohn’s Disease But Not Ulcerative Colitis
Open: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium
Development and Validation of a Scoring System to Predict Outcomes of Vedolizumab Treatment in Patients With Crohn’s Disease
Retrospective Analysis of Safety of Vedolizumab in Patients With Inflammatory Bowel Diseases
Predictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel Disease
OP025 Comparative effectiveness of vedolizumab and tumour necrosis factor-antagonist therapy in Crohn’s disease: a multicentre consortium propensity score-matched analysis
Adherent-invasive <i>Escherichia coli</i> in inflammatory bowel disease